BVS vs ED · rev $573.3M vs P/E 18, rev $15.26B
Bioventus Inc (BVS) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
BVS currently screens at market cap $495.1M. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the BVS and ED stock pages for the full models.
Not investment advice.